| Identification | More | [Name]
Ne-Boc-L-lysine | [CAS]
2418-95-3 | [Synonyms]
H-L-LYS(BOC)-OH
H-LYS(BOC)-OH
L-LYSINE(BOC)
LYS(BOC)
LYSINE(BOC)-OH
N-ALPHA-T-BOC-L-LYS
NEPSILON-BOC-L-LYSINE
N-EPSILON-T-BOC-L-LYSINE
N-EPSILON-T-BUTOXYCARBONYL-L-LYSINE
N-EPSILON-(TERT-BUTOXYCARBONYL)-L-LYSINE
N-EPSILON-TERT-BUTYLOXYCARBONYL-L-LYSINE
epsilon-tert-butyloxycarbonyl-lysine
N-EPSILON-(TERT-BUTOXYCARBONYL)-L-LYSINE 97%
N-epsilon-Boc-L-lysine,99%
e-BOC-L-lysine.
L-LYS(BOC)
N-EPSILON-T-BUTYLOXYCARBONYL-L-LYSINE
Ne-Boc-L-lysine
BOC-L-LYSINE extrapure | [Molecular Formula]
C11H22N2O4 | [MDL Number]
MFCD00037221 | [Molecular Weight]
246.3 | [MOL File]
2418-95-3.mol |
| Chemical Properties | Back Directory | [Appearance]
white crystalline powder | [Melting point ]
250 °C (dec.)(lit.)
| [alpha ]
17 º (c=1% in acetic acid) | [Boiling point ]
389.3°C (rough estimate) | [density ]
1.1313 (rough estimate) | [refractive index ]
18 ° (C=1, AcOH) | [storage temp. ]
2-8°C
| [solubility ]
Soluble in DMSO | [form ]
powder to crystal | [pka]
2.53±0.24(Predicted) | [color ]
White to Almost white | [optical activity]
[α]20/D +18°, c = 1 in acetic acid | [Water Solubility ]
Slightly soluble in water. | [BRN ]
2417626 | [InChIKey]
VVQIIIAZJXTLRE-QMMMGPOBSA-N | [CAS DataBase Reference]
2418-95-3(CAS DataBase Reference) |
| Hazard Information | Back Directory | [Chemical Properties]
white crystalline powder | [Uses]
It is used as therapy to treat recurrent herpes simplex infections. | [General Description]
H-Lys(Boc)-OH, also known as H-Lys(t-BOC)-OH, is an ε-amino-protected lysine. Its e-amino free lysine could be conjugated to polyurethane surfaces by reaction of the alpha-amino group with the NHS and deprotection. The covalent conjugation was carried out in phosphate-buffered saline (PBS), pH 8.2. Lysine was used to create a plasminogen-binding potentially fibrinolytic surface[1]. | [References]
[1] Chen H , et al. Surfaces having dual fibrinolytic and protein resistant properties by immobilization of lysine on polyurethane through a PEG spacer. Journal of Biomedical Materials Research Part A, 2008; 90A: 940-946. | [reaction suitability]
reaction type: solution phase peptide synthesis |
|
|